Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

105 ta ish

Ish: Trogocytosis in cancer immunity and cellular immunotherapy: mechanisms, therapeutic challenges, and translational opportunities

  1. The paths and challenges of “off-the-shelf” CAR-T cell therapy: An overview of clinical trials

    Vahid Moradi, Azadeh Omidkhoda, Naser Ahmadbeigi

    Sharh maqola20239 iqtibos
    ABI

  2. CAR-T cell therapy for cancer: current challenges and future directions

    Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt +7

    Sharh maqola20259 iqtibos
    ABI

  3. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

    Enli Liu, David Marín, Pinaki P. Banerjee +24

    Maqola20207 iqtibos
    ABI

  4. Harnessing the potential of gene editing technology for CAR-T cell therapy of solid tumors

    Elnaz Khodabandehloo, Mohammad Rayati, Ehsan Ahmadi +3

    Maqola20257 iqtibos
    ABI

  5. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

    Noopur Raje, Jesús G. Berdeja, Yi Lin +20

    MaqolaOchiq kirish20195 iqtibos
    ABI

  6. Structural Organization of Vitelline Cells of Trematode with Undifferentiated Body of <i>Azygia Lucii</i> (Muller, 1776)

    Rimma Ualiyeva, Sayan Zhangazin, Indira Bulatovna Altayeva

    MaqolaOchiq kirish20225 iqtibos
    ABI

  7. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

    Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

    MaqolaCAR-T cell therapy researchClinical & Translational Oncology20264 iqtibos
    ABI

  8. Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy

    Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh +2

    Sharh maqola20254 iqtibos
    ABI

  9. Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple Myeloma

    Sylvain Simon, Stanley R. Riddell

    Boshqa20203 iqtibos
    ABI

  10. Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape

    You Zhai, Yicong Du, Guanzhang Li +9

    Maqola20233 iqtibos
    ABI

  11. Sarlavhasiz

    Boshqa3 iqtibos
    ABI

  12. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

    Frederick L. Locke, David B. Miklos, Caron A. Jacobson +28

    Maqola20212 iqtibos
    ABI

  13. KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

    Ye Li, Rafet Başar, Guohui Wang +29

    Maqola20222 iqtibos
    ABI

  14. Non-viral chimeric antigen receptor (CAR) T cells going viral

    Hyatt Balke‐Want, Vimal Keerthi, Amaia Cadiñanos-Garai +6

    Sharh maqola20232 iqtibos
    ABI

  15. Trogocytosis-mediated immune evasion in the tumor microenvironment

    Jeonghyun Kim, So Yeon Park, Jungseo Kim +6

    Sharh maqola20252 iqtibos
    ABI

  16. Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis

    Hanke L. Matlung, Liane Babes, Xi Zhao +26

    Maqola20182 iqtibos
    ABI

  17. The landscape of CAR-engineered innate immune cells for cancer immunotherapy

    Ourania Tsahouridis, Max Xu, Feifei Song +2

    Sharh maqola20252 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa2 iqtibos
    ABI